Feagan BG - Search Results

1

Intravenous cyclosporine for severe attacks of ulcerative colitis: a survey of Canadian gastroenterologists.

Atkinson KA, McDonald JW, Lamba B, Feagan BG. Atkinson KA, et al. Among authors: feagan bg. Can J Gastroenterol. 1997 Oct;11(7):583-7. Can J Gastroenterol. 1997. PMID: 9395759 Clinical Trial.

2

Low-dose cyclosporine for the treatment of Crohn's disease. The Canadian Crohn's Relapse Prevention Trial Investigators.

Feagan BG, McDonald JW, Rochon J, Laupacis A, Fedorak RN, Kinnear D, Saibil F, Groll A, Archambault A, Gillies R, et al. Feagan BG, et al. N Engl J Med. 1994 Jun 30;330(26):1846-51. doi: 10.1056/NEJM199406303302602. N Engl J Med. 1994. PMID: 8196727 Free article. Clinical Trial.

3

Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group.

Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JW. Irvine EJ, et al. Gastroenterology. 1994 Feb;106(2):287-96. doi: 10.1016/0016-5085(94)90585-1. Gastroenterology. 1994. PMID: 8299896 Clinical Trial.

4

Therapeutics and inflammatory bowel disease: a guide to the interpretation of randomized controlled trials.

Feagan BG, McDonald JW, Koval JJ. Feagan BG, et al. Gastroenterology. 1996 Jan;110(1):275-83. doi: 10.1053/gast.1996.v110.pm8536868. Gastroenterology. 1996. PMID: 8536868

5

Cyclosporin in Crohn's disease.

Feagan BG, McDonald JW. Feagan BG, et al. Lancet. 1997 May 3;349(9061):1328. doi: 10.1016/S0140-6736(05)62547-0. Lancet. 1997. PMID: 9142094 No abstract available.

6

Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.

Sandborn WJ, Tremaine WJ, Wolf DC, Targan SR, Sninsky CA, Sutherland LR, Hanauer SB, McDonald JW, Feagan BG, Fedorak RN, Isaacs KL, Pike MG, Mays DC, Lipsky JJ, Gordon S, Kleoudis CS, Murdock RH Jr. Sandborn WJ, et al. Among authors: feagan bg. Gastroenterology. 1999 Sep;117(3):527-35. doi: 10.1016/s0016-5085(99)70445-2. Gastroenterology. 1999. PMID: 10464128 Clinical Trial.

7

A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Koval J, Wong CJ, Hopkins M, Hanauer SB, McDonald JW. Feagan BG, et al. N Engl J Med. 2000 Jun 1;342(22):1627-32. doi: 10.1056/NEJM200006013422202. N Engl J Med. 2000. PMID: 10833208 Free article. Clinical Trial.

8

Annual cost of care for Crohn's disease: a payor perspective.

Feagan BG, Vreeland MG, Larson LR, Bala MV. Feagan BG, et al. Am J Gastroenterol. 2000 Aug;95(8):1955-60. doi: 10.1111/j.1572-0241.2000.02261.x. Am J Gastroenterol. 2000. PMID: 10950042

9

Infliximab in the treatment of Crohn's disease.

Feagan B. Feagan B. Can J Gastroenterol. 2000 Sep;14 Suppl C:6C. doi: 10.1155/2000/809282. Can J Gastroenterol. 2000. PMID: 11023553 No abstract available.

10

Mesalamine maintenance therapy for Crohn's disease.

Feagan BG, McDonald JW. Feagan BG, et al. Gastroenterology. 2001 Feb;120(2):585-6. doi: 10.1053/gast.2001.22159. Gastroenterology. 2001. PMID: 11271451 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

498 results

Search Page